Search for Clinical Trial Results
Acute Myelomonocytic Leukemia - 190 Studies Found
| Status | Study |
| Completed |
Study Name: Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia Condition:
Interventions: Other: laboratory biomarker analysis Correlative studies |
| Active, not recruiting |
Study Name: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Condition:
|
| Completed |
Study Name: Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia Condition:
|
| Completed |
Study Name: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia Condition:
|
| Active, not recruiting |
Study Name: Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders Condition:
|
| Active, not recruiting |
Study Name: Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia Condition:
|
| Active, not recruiting |
Study Name: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant Condition:
|
| Completed |
Study Name: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase Condition:
|
| Completed |
Study Name: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia Condition:
|